Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format

Assay and Drug Development Technologies

Volumn 9, Issue 2, 2011, Pages 165-173

  Tian, Xufan ^a   Isamiddinova, Nigora S ^a   Peroutka, Raymond J ^b   Goldenberg, Seth J ^a   Mattern, Michael R ^a   Nicholson, Benjamin ^a   Leach, Craig ^a  

^a Progenra Inc   (United States)

^b LifeSensors Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; HYBRID PROTEIN; P 022077; P 5091; PEPTIDASE; PR 619; PROTEIN SENP2; PROTEINASE; PROTEINASE INHIBITOR; RECOMBINANT PROTEIN; SUMO 3 PROTEIN; SUMO PROTEIN; UBIQUITIN ISOPEPTIDASE; UBIQUITIN LIKE PROTEASE; UBIQUITIN LIKE PROTEASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; DRUG COST; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME SPECIFICITY; FLUORESCENCE; IC 50; SIGNAL TRANSDUCTION; TREATMENT FAILURE; UBIQUITINATION;

CLINICAL LABORATORY TECHNIQUES; FLUORESCENCE; FLUORESCENT DYES; PICHIA; PROTEASE INHIBITORS; SUBSTRATE SPECIFICITY; UBIQUITIN; UBIQUITINS;

EID: 79953778442     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2010.0317     Document Type: Article

References (37)

1. Schwartz AL, Ciechanover A: Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 2009;49:73-96.
2. Chen BB, Mallampalli RK: Masking of a nuclear signal motif by monoubiquitination leads to mislocalization and degradation of the regulatory enzyme cytidylyltransferase. Mol Cell Biol 2009;29:3062-3075.
3. Ravid T, Hochstrasser M: Diversity of degradation signals in the ubiquitin-proteasome system. Nat Rev 2008;9:679-690.
4. Hochstrasser M: Origin and function of ubiquitin-like proteins. Nature 2009;458:422-429.
5. Haas AL: Structural insights into early events in the conjugation of ubiquitin and ubiquitin-like proteins. Mol Cell 2007;27:174-175.
6. Chen ZJ, Sun LJ: Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 2009;33:275-286.
7. Yin H, Gui Y, Du G, Frohman MA, Zheng XL: Dependence of phospholipase D1 multi-monoubiquitination on its enzymatic activity and palmitoylation. J Biol Chem 2010;285:13580-13588.
8. Li W, Ye Y: Polyubiquitin chains: functions, structures, and mechanisms. Cell Mol Life Sci 2008;65:2397-2406.
9. Pickart CM, Fushman D: Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol 2004;8:610-616. (Pubitemid 39535722)
10. Pickart CM: Targeting of substrates to the 26S proteasome. FASEB J 1997;11:1055-1066.
11. Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J, Rush J, Hochstrasser M, Finley D, Peng J: Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009;137:133-145.
12. Vertegaal AC: Small ubiquitin-related modifiers in chains. Biochem Soc Trans 2007;35:1422-1423.
13. Tatham MH, Jaffray E, Vaughan OA, Desterro JM, Botting CH, Naismith JH, Hay RT: Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 2001;276:35368-35374.
14. Cho G, Lim Y, Golden JA: SUMO interaction motifs in Sizn1 are required for promyelocytic leukemia protein nuclear body localization and for transcriptional activation. J Biol Chem 2009;284:19592-19600.
15. Du JX, Bialkowska AB, McConnell BB, Yang VW: SUMOylation regulates nuclear localization of Kruppel-like factor 5. J Biol Chem 2008;283:31991-32002.
16. Read MA, Brownell JE, Gladysheva TB, Hottelet M, Parent LA, Coggins MB, Pierce JW, Podust VN, Luo RS, Chau V, Palombella VJ: Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol 2000;20:2326-2333. (Pubitemid 30152040)
17. Morimoto M, Nishida T, Honda R, Yasuda H: Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1). Biochem Biophys Res Commun 2000;270:1093-1096. (Pubitemid 30444836)
18. Amerik AY, Hochstrasser M: Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 2004;1695:189-207. (Pubitemid 39574973)
19. Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R: A genomic and functional inventory of deubiquitinating enzymes. Cell 2005;123:773-786. (Pubitemid 41721026)
20. Nicholson B, Marblestone JG, Butt TR, Mattern MR: Deubiquitinating enzymes as novel anticancer targets. Future Oncol 2007;3:191-199. (Pubitemid 46592727)
21. Shanmugham A, Ovaa H: DUBs and disease: activity assays for inhibitor development. Curr Opin Drug Discov Devel 2008;11:688-696.
22. Reyes-Turcu FE, Ventii KH, Wilkinson KD: Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 2009;78:363-397.
23. Rytkonen A, Poh J, Garmendia J, Boyle C, Thompson A, Liu M, Freemont P, Hinton JC, Holden DW: SseL, a Salmonella deubiquitinase required for macrophage killing and virulence. Proc Natl Acad Sci USA 2007;104:3502-3507. (Pubitemid 46364188)
24. Catic A, Misaghi S, Korbel GA, Ploegh HL: ElaD, a Deubiquitinating protease expressed by E. coli. PLoS ONE 2007;2:e381.
25. Chen Z, Wang Y, Ratia K, Mesecar AD, Wilkinson KD, Baker SC: Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. J Virol 2007;81:6007-6018. (Pubitemid 46847037)
26. Tirat A, Schilb A, Riou V, Leder L, Gerhartz B, Zimmermann J, Worpenberg S, Eidhoff U, Freuler F, Stettler T, Mayr L, Ottl J, Leuenberger B, Filipuzzi I: Synthesis and characterization of fluorescent ubiquitin derivatives as highly sensitive substrates for the deubiquitinating enzymes UCH-L3 and USP-2. Anal Biochem 2005;343:244-255. (Pubitemid 41074037)
27. Dang LC, Melandri FD, Stein RL: Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. Biochemistry 1998;37:1868-1879. (Pubitemid 28099809)
28. Nicholson B, Leach CA, Goldenberg SJ, Francis DM, Kodrasov MP, Tian X, Shanks J, Sterner DE, Bernal A, Mattern MR, Wilkinson KD, Butt TR: Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities. Protein Sci 2008;17:1035-1043. (Pubitemid 351749209)
29. Leach CA, Tian X, Mattern MR, Nicholson B: Detection and characterization of SUMO protease activity using a sensitive enzyme-based reporter assay. Methods Mol Biol 2009;497:269-281.
30. Cao P, Nicholson B, Weinstock J, Kingsbury W, Mattern MR, Goldenberg SJ, McDermott J, Leach CA, Kizhakkethil-George SK, Butt TR: Antineoplastic methods, compounds and compositions, Patent Application, PCT/US2010/029358. 2009.
31. Gasparian ME, Ostapchenko VG, Schulga AA, Dolgikh DA, Kirpichnikov MP: Expression, purification, and characterization of human enteropeptidase catalytic subunit in Escherichia coli. Protein Expr Purif 2003;31:133-139. (Pubitemid 37207651)
32. Song HW, Choi SI, Seong BL: Engineered recombinant enteropeptidase catalytic subunit: effect of N-terminal modification. Arch Biochem Biophys 2002;400:1-6.
33. McGuire MJ, Lipsky PE, Thiele DL: Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J Biol Chem 1993;268:2458-2467. (Pubitemid 23057866)
34. Cheon KW, Baek KH: HAUSP as a therapeutic target for hematopoietic tumors (review). Int J Oncol 2006;28:1209-1215.
35. Ponts N, Yang J, Chung DW, Prudhomme J, Girke T, Horrocks P, Le Roch KG: Deciphering the ubiquitin-mediated pathway in apicomplexan parasites: a potential strategy to interfere with parasite virulence. PLoS ONE 2008;3:e2386.
36. Bross PF, Kane R, Farrell AT, Abraham S, Benson K, Brower ME, Bradley S, Gobburu JV, Goheer A, Lee SL, Leighton J, Liang CY, Lostritto RT, McGuinn WD, Morse DE, Rahman A, Rosario LA, Verbois SL, Williams G, Wang YC, Pazdur R: Approval summary for bortezomib for injection in the treatment of multiple myeloma. Clin Cancer Res 2004;10:3954-3964. (Pubitemid 38812468)
37. Brownell JE, Sintchak MD, Gavin JM, Liao H, Bruzzese FJ, Bump NJ, Soucy TA, Milhollen MA, Yang X, Burkhardt AL, Ma J, Loke HK, Lingaraj T, Wu D, Hamman KB, Spelman JJ, Cullis CA, Langston SP, Vyskocil S, Sells TB, Mallender WD, Visiers I, Li P, Claiborne CF, Rolfe M, Bolen JB, Dick LR: Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol Cell 2010;37:102-111.